0 Commenti
0 condivisioni
46 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
- Effettua l'accesso per mettere mi piace, condividere e commentare!
- Gabapentin Market Expanding Neuropathic Pain and Epilepsy Treatments"Comprehensive Outlook on Executive Summary Gabapentin Market Size and Share CAGR Value Data Bridge Market Research analyses that the global gabapentin market which was USD 2,472.84 million in 2022, is expected to reach USD 3,021.80 million by 2030, and is expected to undergo a CAGR of 2.6% during the forecast period 2023-2030. Gabapentin Market research report unearths different...0 Commenti 0 condivisioni 924 Views 0 Anteprima
- Market Dynamics and Strategic Insights: Navigating the global ready to global epilepsy drugs marketMarket Overview The epilepsy drugs market size was valued at USD 11.20 billion in 2024 and is expected to register a CAGR of 5.7% from 2025 to 2034. Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. It affects approximately 50 million people worldwide, making it one of the most common neurological diseases globally. The management of epilepsy primarily...0 Commenti 0 condivisioni 867 Views 0 Anteprima
- Paediatric Epilepsy Therapeutics Market Forecast 2025–2035: Trends, Share, Growth Drivers & Key Players"Executive Summary Paediatric Epilepsy Therapeutics Market Research: Share and Size Intelligence The expected CAGR of paediatric epilepsy therapeutics market is tend to be around 5% in the mentioned forecast period. The market was valued at USD 11.45 billion in 2022, and it would grow up to USD 16.91 billion by 2030. Market research studies stated in this Paediatric Epilepsy...0 Commenti 0 condivisioni 957 Views 0 Anteprima
- Paediatric Epilepsy Therapeutics Market: Anti-Epileptic Drugs (AEDs), Ketogenic Diet, and Treatment Strategies for Pediatric Neurological DisordersExecutive Summary: The Global Paediatric Epilepsy Therapeutics Market focuses on the medications, devices, and specialized treatments used to manage seizure disorders in children, from neonates through adolescents. This market is highly dynamic, driven by the unique challenges of treating developing brains and the prevalence of drug-resistant epilepsy (DRE) syndromes specific to this age...0 Commenti 0 condivisioni 264 Views 0 Anteprima
- Petit Mal Treatment Market: Pediatric Epilepsy Therapeutics, Novel Antiepileptic Drug (AED) Pipeline, and Home Care Monitoring Trends"Executive Summary Petit Mal Treatment Market: Share, Size & Strategic Insights Data Bridge Market Research analyses a growth rate in the global petit mal treatment market in the forecast period 2022-2029. The key topics that have been described in this Petit Mal Treatment Market report include market definition, market segmentation, key developments, competitive analysis, and research...0 Commenti 0 condivisioni 215 Views 0 Anteprima
- Pregabalin Market Opportunities: Growth, Share, Value, Size, and Scope"Executive Summary Pregabalin Market Size, Share, and Competitive Landscape The global pregabalin market size was valued at USD 853.86 Million in 2024 and is expected to reach USD 1,126.98 Million by 2032, at a CAGR of 3.53% during the forecast period This Pregabalin Market report has been generated by keeping in mind all the requirements of the...0 Commenti 0 condivisioni 1919 Views 0 Anteprima
- Pregabalin Market Opportunities: Growth, Share, Value, Size, and Scope"Executive Summary Pregabalin Market Size, Share, and Competitive Landscape The global pregabalin market size was valued at USD 853.86 Million in 2024 and is expected to reach USD 1,126.98 Million by 2032, at a CAGR of 3.53% during the forecast period This Pregabalin Market report has been generated by keeping in mind all the requirements of the...0 Commenti 0 condivisioni 288 Views 0 Anteprima
- Why Doctors Prescribe Oxcarb 300 for Epilepsy Management | Uses & BenefitsEpilepsy is a chronic neurological condition that requires long-term, carefully monitored treatment. Among the many antiepileptic medications available today, Oxcarb 300 , which is also known as Oxcarbazepine 300 mg, has gained significant recognition for its effectiveness and safety profile. Neurologists frequently prescribe this medication to help control seizures, particularly partial...0 Commenti 0 condivisioni 98 Views 0 Anteprima
© 2026 La Lingua Nostra
Italiano